These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37129682)

  • 21. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
    Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
    Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller.
    Hung JJ; Yeh YC; Jeng WJ; Wu YC; Chou TY; Hsu WH
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):329-36. PubMed ID: 26819290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J; Hida Y; Kaga K; Ohtaka K; Okamoto S; Tamaki N; Nakada-Kubota R; Hirano S; Matsui Y
    Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors for Occult Lymph Node Metastasis in Peripheral Non-Small Cell Lung Cancer with Invasive Component Size 3 cm or Less.
    Moon Y; Choi SY; Park JK; Lee KY
    World J Surg; 2020 May; 44(5):1658-1665. PubMed ID: 31912252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with lymph node metastasis upstage after resection for patients with micropapillary lung adenocarcinoma.
    Matsushima K; Sonoda D; Mitsui A; Tamagawa S; Hayashi S; Naito M; Matsui Y; Shiomi K; Satoh Y
    Thorac Cancer; 2022 Jan; 13(1):48-53. PubMed ID: 34866323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and computed tomographic features associated with occult lymph node metastasis in patients with peripheral solid non-small cell lung cancer.
    He XQ; Luo TY; Li X; Huo JW; Gong JW; Li Q
    Eur J Radiol; 2021 Nov; 144():109981. PubMed ID: 34624648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
    Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
    Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Utility of SUVmax as an Adaptation Criterion for Limited Resection in Stage IA Non-Small Cell Lung Cancer.
    Motono N; Mizoguchi T; Ishikawa M; Iwai S; Iijima Y; Uramoto H
    Oncology; 2023; 101(8):473-480. PubMed ID: 37433283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a primary tumor and lymph node 18F-FDG PET/CT-clinical (TLPC) model to predict lymph node metastasis of resectable T2-4 NSCLC.
    Wang M; Liu L; Dai Q; Jin M; Huang G
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):247-261. PubMed ID: 36565319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomics Analysis and Nomogram Risk Prediction of Occult Lymph Node Metastasis in Non-Predominant Micropapillary Component of Lung Adenocarcinoma Measuring ≤ 3 cm.
    Wang K; Xue M; Qiu J; Liu L; Wang Y; Li R; Qu C; Yue W; Tian H
    Front Oncol; 2022; 12():945997. PubMed ID: 35912197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation study between flash dual source CT perfusion imaging and regional lymph node metastasis of non-small cell lung cancer.
    Huang T; Sun H; Luo X; Zhang X; Jin K; Wang F; Sun L; Cheng N; Wu S; Lou Q; Li B
    BMC Cancer; 2020 Jun; 20(1):547. PubMed ID: 32532248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT Radiomics-Based Nomogram for Predicting the Lateral Neck Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Prospective Multicenter Study.
    Dong L; Han X; Yu P; Zhang W; Wang C; Sun Q; Song F; Zhang H; Zheng G; Mao N; Song X
    Acad Radiol; 2023 Dec; 30(12):3032-3046. PubMed ID: 37210266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma.
    Meng ZW; Lin XQ; Zhu JH; Han SH; Chen YL
    J Surg Res; 2018 Jun; 226():56-63. PubMed ID: 29661289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical impact and utility of positron emission tomography on occult lymph node metastasis and survival: radical surgery for stage I lung cancer.
    Hino H; Utsumi T; Maru N; Matsui H; Taniguchi Y; Saito T; Murakawa T
    Gen Thorac Cardiovasc Surg; 2021 Aug; 69(8):1196-1203. PubMed ID: 33609239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative prediction of mediastinal lymph node metastasis in non-small cell lung cancer based on
    Huang Y; Jiang X; Xu H; Zhang D; Liu LN; Xia YX; Xu DK; Wu HJ; Cheng G; Shi YH
    Clin Radiol; 2023 Jan; 78(1):8-17. PubMed ID: 36192203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomograms for intraoperative prediction of lymph node metastasis in clinical stage IA lung adenocarcinoma.
    Li F; Zhai S; Fu L; Yang L; Mao Y
    Cancer Med; 2023 Jul; 12(13):14360-14374. PubMed ID: 37212495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Three Dimensional Measurement of the Space Distance Between the Hilum and Clinical Stage T
    Li G; Deng HY; Luo J; Wang YC; Alaiguha ; Zhuo ZG; Shen X; Lin YD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):526-532. PubMed ID: 32691562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Potential value of FDG PET-CT in predicting occult lymph node metastasis in clinical stage ⅠA lung adenocarcinoma].
    Lyu L; Liu Y; Wang XY; Zhang ZK; Tao XL; Yang L; Wu N
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):441-447. PubMed ID: 31216830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.